Despite what may seem rather clear and obvious, there will still be rogues. We have to be alert: Sanjay Vyas, Managing Director, Parexel India

The industry is still growing, like more clinical development work is happening, more trials are coming here. There was a kind of a bump during COVID era where work from start-ups were very high, but a lot of that was just COVID related. I think it has stabilised again and the industry fundamental is very strong. APAC is still very important. Even within that India is super important. 6,000 people work here, that's 25 per cent of our workforce.

from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/HyWIzev